Learn About Ruvalcaba Syndrome

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Ruvalcaba Syndrome Local Doctors?
Learn about our expert tiers
Learn more
What are the Latest Advances for Ruvalcaba Syndrome?
Multiple basal cell carcinomas in Gorlin Syndrome treated with pulsed dye laser.
Lhermitte-Duclos disease: A case report and literature review.
Tired of the same old research?
Check Latest Advances
A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN.
What are the latest Ruvalcaba Syndrome Clinical Trials?
A Multi-Cohort Phase 2 Dose-Escalation Study of MK-7075 (Miransertib) in Proteus Syndrome

Background: Proteus syndrome is a rare overgrowth disorder. Most people begin to have symptoms between 6 months and 2 years of age. There are very few living adults with this disease. There is also no known treatment for it. Researchers want to see if a new drug can slow down or stop overgrowth in people with Proteus syndrome.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Familial Investigations of Childhood Cancer Predisposition

Summary: NOTE: This is a research study and is not meant to be a substitute for clinical genetic testing. Families may never receive results from the study or may receive results many years from the time they enroll. If you are interested in clinical testing please consider seeing a local genetic counselor or other genetics professional. If you have already had clinical genetic testing and meet eligibility...